Roivant Sciences Ltd. Common Shares (ROIV) — Analysis Summary
Roivant Sciences Ltd. Common Shares (ROIV) has a market cap of $20.42B with year-over-year revenue growth of -76.7%. Net margin stands at -592.0%. The stock trades at a P/E ratio of -118.7.
Key Takeaways
- Revenue changed -76.7% year-over-year
- Net margin of -592.0%
- P/E ratio of -118.7
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ROIV posted revenue growth of -76.7% and trades at a P/E of -118.7.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.